Acquisition by Roemer Alan S. of 33650 shares of In8bio at 1.47 subject to Rule 16b-3
| INAB Stock | USD 0.26 0.01 4.00% |
About 55% of In8bio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding In8bio Inc suggests that some traders are interested. The current market sentiment, together with In8bio's historical and current headlines, can help investors time the market. In addition, many technical investors use In8bio Inc stock news signals to limit their universe of possible portfolio assets.
In8bio |
Filed transaction by In8bio Inc Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
In8bio Fundamental Analysis
We analyze In8bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In8bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In8bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
In8bio is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
In8bio Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with In8bio stock to make a market-neutral strategy. Peer analysis of In8bio could also be used in its relative valuation, which is a method of valuing In8bio by comparing valuation metrics with similar companies.
Peers
In8bio Related Equities
| ZURA | Zura Bio | 6.82 | ||||
| CUE | Cue Biopharma | 6.62 | ||||
| LTRN | Lantern Pharma | 2.91 | ||||
| RVPH | Reviva Pharmaceuticals | 2.72 | ||||
| INMB | INmune Bio | 1.77 | ||||
| ANNX | Annexon | 1.94 | ||||
| ANIX | Anixa Biosciences | 2.00 | ||||
| GANX | Gain Therapeutics | 3.18 | ||||
| WVE | Wave Life | 4.06 | ||||
| PYPD | PolyPid | 4.35 | ||||
| PALI | Palisade Bio | 4.90 | ||||
| ALLR | Allarity Therapeutics | 5.08 | ||||
| WINT | Windtree Therapeutics | 7.14 |
Complementary Tools for In8bio Stock analysis
When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |